Hyperthermic effects of D-lysergic acid diethylamide (LSD) and its derivatives in rabbits and rats
- PMID: 303504
Hyperthermic effects of D-lysergic acid diethylamide (LSD) and its derivatives in rabbits and rats
Abstract
Several D-lysergic acid diethylamide (LSD) derivatives including metabolites of LSD in animals liver and Streptomyces such as D-lysergic acid ethyl, 2-hydroxyethylamide (LEO), D-lysergic acid ethylamide (LAE), D-norlysergic acid diethylamide (norLSD) and synthetic N6-allyl-D-norlysergic acid diethylamide (allyl-nor LSD) were studied with rabbits and rats. In rabbits, the order of the hyperthermic activities was allyl-norLSD greater than LSD greater than LEO, LAE, nor-LSD, and this order was parallel to that of 5-hydroxytryptamine-like activities of these compounds which was previously studied. However, the order was LAE greater than LSD greater than norLSD IN RATS. The hyperthermic effect of LSD in rabbits was attenuated by methysergide, but not by atropine when these drugs were intraventricularly administered. These results suggest the possibility that the metabolites of LSD contribute to the hyperthermic effect of LSD in rats but not in rabbits, and support the idea that 5-HT receptors are involved in the hyperthermia induced by LSD in rabbits.
Similar articles
-
Dual actions of lysergic acid diethylamide tartrate (LSD), 2-bromo-D-lysergic acid diethylamide bitartrate (BOL) and methysergide on dorsal root potentials evoked by stimulation of raphe nuclei.J Pharmacol Exp Ther. 1981 Apr;217(1):99-104. J Pharmacol Exp Ther. 1981. PMID: 6110778
-
Serotonin antagonists and central hyperthermia produced by biogenic amines in conscious rabbits.Eur J Pharmacol. 1979 Jan 1;53(2):191-200. doi: 10.1016/0014-2999(79)90165-1. Eur J Pharmacol. 1979. PMID: 32059
-
Evidence for a central 5-hydroxytryptamine receptor stimulation by lysergic acid diethylamide.Br J Pharmacol. 1968 Sep;34(1):1-7. doi: 10.1111/j.1476-5381.1968.tb07943.x. Br J Pharmacol. 1968. PMID: 5302837 Free PMC article.
-
LSD, 5-HT (serotonin), and the evolution of a behavioral assay.Neurosci Biobehav Rev. 2004 Jan;27(8):693-701. doi: 10.1016/j.neubiorev.2003.11.012. Neurosci Biobehav Rev. 2004. PMID: 15019419 Review.
-
Antagonist properties of d-LSD at 5-hydroxytryptamine2 receptors.Neuropsychopharmacology. 1990 Oct-Dec;3(5-6):503-8. Neuropsychopharmacology. 1990. PMID: 2078283 Review.
Cited by
-
Return of the lysergamides. Part II: Analytical and behavioural characterization of N6 -allyl-6-norlysergic acid diethylamide (AL-LAD) and (2'S,4'S)-lysergic acid 2,4-dimethylazetidide (LSZ).Drug Test Anal. 2017 Jan;9(1):38-50. doi: 10.1002/dta.1985. Epub 2016 Jun 6. Drug Test Anal. 2017. PMID: 27265891 Free PMC article.
-
Analytical profile, in vitro metabolism and behavioral properties of the lysergamide 1P-AL-LAD.Drug Test Anal. 2022 Aug;14(8):1503-1518. doi: 10.1002/dta.3281. Epub 2022 May 29. Drug Test Anal. 2022. PMID: 35524430 Free PMC article.
-
Return of the lysergamides. Part III: Analytical characterization of N6 -ethyl-6-norlysergic acid diethylamide (ETH-LAD) and 1-propionyl ETH-LAD (1P-ETH-LAD).Drug Test Anal. 2017 Oct;9(10):1641-1649. doi: 10.1002/dta.2196. Epub 2017 May 10. Drug Test Anal. 2017. PMID: 28342178 Free PMC article.